SAIZEN Side Effects

7015291-0 | Haemorrhage, Pilonidal Cyst
on Sep 24, 2010 Male patient from FRANCE , weighting 180.8 lb, was diagnosed with growth hormone deficiency, blood corticotrophin decreased, blood thyroid stimulating hormone decreased, diabetes mellitus, hyperuricaemia, epilepsy (What is epilepsy?), depression (What is depression?), gonadotrophin deficiency and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, pilonidal cyst. Saizen dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), LEVOTHYROXISO (View Levothyroxiso Review and Levothyroxiso Label ), MINIRIN (View Minirin Review and Minirin Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), PROZAC (View Prozac Review and Prozac Label ), ANDROTARDYL (View Androtardyl Review and Androtardyl Label ). Patient was hospitalized.

6975684-4 | Cardiac Failure, Respiratory Disorder
Patient was taking Saizen (View Usage). Patient had the following side effects: cardiac failure, respiratory disorder on Sep 02, 2010 from ITALY Additional patient health information: Male patient , 77 years of age, . Saizen dosage: .

6970103-6 | Febrile Convulsion, Insulin-like Growth Factor Increased
Adverse event was reported on Aug 27, 2010 by a Female patient taking Saizen (View Usage) (Dosage: ) was diagnosed with growth hormone deficiency and. Location: UNITED STATES , weighting 61.73 lb, After Saizen was administered, patient had the following side effects: febrile convulsion, insulin-like growth factor increased.

6969669-1 | Heart Rate Increased, Oxygen Saturation Decreased, Respiratory Rate Increased
on Aug 30, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, oxygen saturation decreased, respiratory rate increased. Saizen dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM (View Calcium Review and Calcium Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ).


6930275-6 | Migraine, Pituitary Tumour Benign, Pituitary-dependent Cushing's Syndrome
on Jul 28, 2010 Female patient from CANADA , 45 years of age, was diagnosed with blood growth hormone and was treated with Saizen (View Usage). Patient had the following side effects: migraine (What is migraine?), pituitary tumour benign, pituitary-dependent cushing's syndrome. Saizen dosage: 1 In 1 D. During the same period patient was treated with T3 (LIOTHYRONINE SODIUM) (View T3 (liothyronine Sodium) Review and T3 (liothyronine Sodium) Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), ESTROGEN (ESTROGEN NOS) (View Estrogen (estrogen Nos) Review and Estrogen (estrogen Nos) Label ), DHEA (PRASTERONE) (View Dhea (prasterone) Review and Dhea (prasterone) Label ), LOW CORTISOL (HYDROCORTISONE) (View Low Cortisol (hydrocortisone) Review and Low Cortisol (hydrocortisone) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6925573-6 | Condition Aggravated, Tourette's Disorder
Patient was taking Saizen (View Usage). After Saizen was administered, patient had the following side effects: condition aggravated, tourette's disorder on Jul 27, 2010 from SPAIN Additional patient health information: Male patient , 13 years of age, weighting 79.37 lb, was diagnosed with body height below normal and. Saizen dosage: , 1 In 1 D, Subcutaneous, 1.1 Mg, 1 In 1 D, Subcutaneous, 1.3 Mg, 1. In 1 D, Subcutaneous. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6917201-0 | Back Pain, Hydronephrosis, Renal Colic
Adverse event was reported on Jul 22, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 1.1 Mg) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , child 6 years of age, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), hydronephrosis, renal colic.

6914981-5 | Convulsion
on Jul 22, 2010 Female patient from UNITED STATES , child 5 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient had the following side effects: convulsion. Saizen dosage: .

6906948-8 | Pneumonia
on Jul 20, 2010 Male patient from UNITED STATES , 16 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: pneumonia (What is pneumonia?). Saizen dosage: 1.6 Mg ; 1.6 Mg. Patient was hospitalized.

6882881-5 | Asphyxia, Aspiration, Dysphagia, Hypersomnia, Hypoxia
Patient was taking Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, aspiration, dysphagia, hypersomnia, hypoxia on Jul 09, 2010 from TURKEY Additional patient health information: Male patient , child 12 years of age, was diagnosed with growth hormone deficiency and. Saizen dosage: 1.4 Mg, 1 In 1 D. During the same period patient was treated with ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ), COUGH SYRUPS (COUGH SYRUP) (View Cough Syrups (cough Syrup) Review and Cough Syrups (cough Syrup) Label ), SPRAY CONTAINING STEROID (CORTICOSTEROIDS) (View Spray Containing Steroid (corticosteroids) Review and Spray Containing Steroid (corticosteroids) Label ).

6874722-7 | Dehydration, Gastrointestinal Viral Infection
Adverse event was reported on Jul 15, 2010 by a Female patient taking Saizen (View Usage) (Dosage: ) . Location: ARGENTINA , child 5 years of age, Patient had the following side effects: dehydration, gastrointestinal viral infection. Patient was hospitalized.

6869681-7 | Asphyxia, Aspiration, Dysphagia, Somnolence
on Jul 09, 2010 Male patient from TURKEY , child 12 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: asphyxia, aspiration, dysphagia, somnolence. Saizen dosage: 1.4 Mg, 1 In 1. During the same period patient was treated with ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ), COUGH SYRUPS (COUGH SYRUP) (View Cough Syrups (cough Syrup) Review and Cough Syrups (cough Syrup) Label ), SPRAY CONTAINING STEROID (CORTICOSTEROIDS) (View Spray Containing Steroid (corticosteroids) Review and Spray Containing Steroid (corticosteroids) Label ).

6865222-9 | Blood Bicarbonate Decreased, Blood Ph Decreased, Dehydration, Pco2 Decreased, Type 1 Diabetes Mellitus
on Jul 07, 2010 Female patient from CANADA , 13 years of age, weighting 103.6 lb, was diagnosed with turner's syndrome and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: blood bicarbonate decreased, blood ph decreased, dehydration, pco2 decreased, type 1 diabetes mellitus. Saizen dosage: 1.75 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ESTRACE (View Estrace Review and Estrace Label ). Patient was hospitalized.

6862401-1 | Blood Sodium Decreased, Chest Pain, Dizziness, Fall, Headache, Hypotension, Spinal Fracture, Vision Blurred, Vomiting
Patient was taking Saizen (View Usage). Patient had the following side effects: blood sodium decreased, chest pain (What is chest pain?), dizziness (What is dizziness?), fall (What is fall?), headache (What is headache?), hypotension, spinal fracture, vision blurred, vomiting on Jul 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 22 years of age, was diagnosed with growth hormone deficiency and. Saizen dosage: 0.2 Mg; 0.4 Mg. Patient was hospitalized.

6862395-9 | Condition Aggravated, Tourette's Disorder
Adverse event was reported on Jul 06, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 1 In 1 D, Subcutaneous; 1.1 Mg, 1 In 1 D, Subcutaneous; 1.3 Mg, 1 In 1 D, Subcutaneous) was diagnosed with body height below normal and. Location: SPAIN , 13 years of age, weighting 79.37 lb, After Saizen was administered, patient had the following side effects: condition aggravated, tourette's disorder. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6857952-X | Asphyxia, Aspiration, Dysphagia, Hypersomnia, Hypoxia
on Jun 30, 2010 Male patient from TURKEY , child 12 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, aspiration, dysphagia, hypersomnia, hypoxia. Saizen dosage: 1.4 Mg, 1 In 1. During the same period patient was treated with ANTIBOTICS (ANTIBOTICS) (View Antibotics (antibotics) Review and Antibotics (antibotics) Label ), COUGH SYRUPS (COUGH SYRUP) (View Cough Syrups (cough Syrup) Review and Cough Syrups (cough Syrup) Label ), SPRAY CONTAINING STEROID (CORTICOSTERODIS) (View Spray Containing Steroid (corticosterodis) Review and Spray Containing Steroid (corticosterodis) Label ).

6846521-3 | Homicidal Ideation, Pollakiuria, Thirst
on Nov 06, 2009 Female patient from UNITED STATES , child 10 years of age, was treated with Saizen (View Usage). Patient had the following side effects: homicidal ideation, pollakiuria, thirst. Saizen dosage: 1.4 Mg.

6843641-4 | Convulsion, Corneal Reflex Decreased, Hypotonia
Patient was taking Saizen (View Usage). After Saizen was administered, patient had the following side effects: convulsion, corneal reflex decreased, hypotonia on Mar 25, 2009 from KOREA, REPUBLIC OF Additional patient health information: Female patient , child 3 years of age, was diagnosed with hypopituitarism and. Saizen dosage: 0.5 Mg, 7 In 1 Wk, Subcutaneous. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ).

6843590-1 | Shunt Malfunction
Adverse event was reported on Jun 28, 2010 by a Male patient taking Saizen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , child 12 years of age, Patient experienced the following unwanted or unexpected effects: shunt malfunction. Patient was hospitalized.

6838609-8 | Osteochondritis
on Jun 23, 2010 Male patient from GREECE , 17 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient had the following side effects: osteochondritis. Saizen dosage: Subcutaneous.

6832355-2 | Hospitalisation
on Jul 07, 2010 Male patient from UNITED KINGDOM , child 12 years of age, was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: hospitalisation. Saizen dosage: 1. Patient was hospitalized.

6831659-7 | Device Related Infection, Peritonitis
Patient was taking Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, peritonitis on Jun 23, 2010 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, . Saizen dosage: 0.75 Mg. Patient was hospitalized.

6812928-3 | Pneumonia Legionella
Adverse event was reported on Jun 14, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 3.3 Mg) was diagnosed with growth hormone deficiency, crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , child 11 years of age, Patient had the following side effects: pneumonia legionella. During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ). Patient was hospitalized.

6800778-3 | Diabetes Insipidus, Dry Mouth, Dysgeusia, Dyspepsia, Fatigue, Fluid Retention, Headache, Injection Site Discomfort, Injection Site Haematoma
on May 20, 2010 Female patient from UNITED KINGDOM , 44 years of age, was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), dry mouth, dysgeusia, dyspepsia, fatigue, fluid retention, headache (What is headache?), injection site discomfort, injection site haematoma. Saizen dosage: 0.3 Mg.

6795593-3 | Convulsion, Hypotonia
on Jun 09, 2010 Female patient from KOREA, REPUBLIC OF , child 3 years of age, was diagnosed with hypopituitarism and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypotonia. Saizen dosage: 0.5 Mg, 7 In 1 Wk, Subcutaneous. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ).

6781692-9 | Abnormal Behaviour, Anxiety, Condition Aggravated, Depression, Fracture, Multiple Injuries, Suicide Attempt
Patient was taking Saizen (View Usage). Patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), condition aggravated, depression (What is depression?), fracture (What is fracture?), multiple injuries, suicide attempt on Jun 09, 2010 from FRANCE Additional patient health information: Female patient , 25 years of age, weighting 173.3 lb, was diagnosed with endocrine disorder and. Saizen dosage: 0.2 Mg, 1 In 1 D, Subcutaneous, 0.2 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with LEVOTHYROX (LEVOTHYROXINE) (View Levothyrox (levothyroxine) Review and Levothyrox (levothyroxine) Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), MINIRIN (View Minirin Review and Minirin Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), XENICAL (View Xenical Review and Xenical Label ), MINIDRIL (EUGYNON) (View Minidril (eugynon) Review and Minidril (eugynon) Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

6780897-0 | Ankle Fracture, Pulmonary Embolism
Adverse event was reported on Jun 03, 2010 by a Male patient taking Saizen (View Usage) (Dosage: Subcutaneous) was diagnosed with growth hormone deficiency and. Location: GREECE , 14 years of age, After Saizen was administered, patient had the following side effects: ankle fracture, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6776514-6 | Ankle Fracture, Pulmonary Embolism
on Jun 03, 2010 Male patient from GREECE , 14 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, pulmonary embolism (What is pulmonary embolism?). Saizen dosage: Subcutaneous. Patient was hospitalized.

6773636-0 | Blood Pressure Orthostatic Decreased, Chest Pain, Dizziness, Feeling Abnormal, Vomiting
on May 14, 2010 Female patient from UNITED KINGDOM , 22 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient had the following side effects: blood pressure orthostatic decreased, chest pain (What is chest pain?), dizziness (What is dizziness?), feeling abnormal, vomiting. Saizen dosage: 0.2 Mg, 0.4 Mg. Patient was hospitalized.

6768272-6 | Contusion, Diabetes Insipidus, Dry Mouth, Dysgeusia, Dyspepsia, Fatigue, Headache, Injection Site Discomfort, Oedema Peripheral
Patient was taking Saizen (View Usage). After Saizen was administered, patient had the following side effects: contusion, diabetes insipidus (What is diabetes insipidus?), dry mouth, dysgeusia, dyspepsia, fatigue, headache (What is headache?), injection site discomfort, oedema peripheral on May 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 44 years of age, . Saizen dosage: 0.3 Mg.

6766856-2 | Pneumonia Mycoplasmal
Adverse event was reported on May 26, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 1.1 Mg, 1 In 1 D,) . Location: UNITED KINGDOM , 14 years of age, weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: pneumonia mycoplasmal. During the same period patient was treated with CLOBAZAM (View Clobazam Review and Clobazam Label ), PENICILLIN (BENZYLPENICILLIN) (View Penicillin (benzylpenicillin) Review and Penicillin (benzylpenicillin) Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6766132-8 | Pneumonia Legionella
on May 27, 2010 Male patient from UNITED STATES , child 11 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient had the following side effects: pneumonia legionella. Saizen dosage: 3.3 Mg. Patient was hospitalized.

6764091-5 |
on May 26, 2010 Male patient from UNITED KINGDOM , 14 years of age, was treated with Saizen (View Usage). . Saizen dosage: .

6761384-2 | Ankle Fracture, Pulmonary Embolism
Patient was taking Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, pulmonary embolism (What is pulmonary embolism?) on May 25, 2010 from GREECE Additional patient health information: Male patient , 14 years of age, was diagnosed with growth hormone deficiency and. Saizen dosage: Subcutaneous. Patient was hospitalized.

6760061-1 | Meningioma
Adverse event was reported on May 20, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 0.24 Mg, 1 In 1 D, Subcutaneous) was diagnosed with growth hormone deficiency and. Location: FRANCE , 30 years of age, weighting 158.7 lb, Patient had the following side effects: meningioma. During the same period patient was treated with GONAL F (View Gonal-f Review and Gonal-f Label ), HCG (CHORIONIC GONADOTROPHIN) (View Hcg (chorionic Gonadotrophin) Review and Hcg (chorionic Gonadotrophin) Label ).

6760059-3 | Condition Aggravated, Depression, Fracture, Multiple Injuries, Suicide Attempt
on May 20, 2010 Female patient from FRANCE , 25 years of age, weighting 173.3 lb, was diagnosed with endocrine disorder and was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: condition aggravated, depression (What is depression?), fracture (What is fracture?), multiple injuries, suicide attempt. Saizen dosage: 0.2 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with LEVOTHYROX (LEVOTHYROXINE) (View Levothyrox (levothyroxine) Review and Levothyrox (levothyroxine) Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), MINIRIN (DESMOPRESSION ACETATE) (View Minirin (desmopression Acetate) Review and Minirin (desmopression Acetate) Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), XENICAL (View Xenical Review and Xenical Label ), MINIDRIL (EUGYNON /00022701/) (View Minidril (eugynon /00022701/) Review and Minidril (eugynon /00022701/) Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

6760057-X | Brain Oedema, Cerebrovascular Disorder, Herpes Pharyngitis, Meningism, Meningitis
on May 20, 2010 Female patient from FRANCE , 56 years of age, weighting 174.2 lb, was diagnosed with hypopituitarism, hypertriglyceridaemia, osteopenia, depression (What is depression?) and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, cerebrovascular disorder, herpes pharyngitis, meningism, meningitis (What is meningitis?). Saizen dosage: 0.8 Mg, 1 In 1 D. During the same period patient was treated with HYDROCORTONE (20 Mg, 1 In 1 D, Oral) (View Hydrocortone Review and Hydrocortone Label ), KLIOGEST (TRISEKVENS /00441501/) (1 Df, 1 In 1d, Oral) (View Kliogest (trisekvens /00441501/) Review and Kliogest (trisekvens /00441501/) Label ), LEVOTHYROXINE SODIUM (100 Mcg, 1 In 1 D, Oral) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FENOFIBRATE (160 Mg, 1 In 1 D, Oral) (View Fenofibrate Review and Fenofibrate Label ), OROCAL D3 (LEKOVIT CA) (1 Df, 1 In 1 D, Oral) (View Orocal D3 (lekovit Ca) Review and Orocal D3 (lekovit Ca) Label ), PROZAC (20 Mg, 1 In 1 D, Oral) (View Prozac Review and Prozac Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ). Patient was hospitalized.

6760005-2 | Depression, Dyslipidaemia, Gastrointestinal Disorder, Hyperprolactinaemia, Magnesium Deficiency, Meningioma Benign
Patient was taking Saizen (View Usage). Patient had the following side effects: depression (What is depression?), dyslipidaemia, gastrointestinal disorder, hyperprolactinaemia, magnesium deficiency, meningioma benign on May 20, 2010 from FRANCE Additional patient health information: Female patient , 37 years of age, weighting 132.3 lb, was diagnosed with growth hormone deficiency and. Saizen dosage: 0.1 Mg, 1 In 1 D, Subcutaneous; 0.1 Mg, 1 In 1 D, Subcutaneous, 0.1 Mg, 1 In 1 D. During the same period patient was treated with HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), MAGNE B6 (MAGNESIUM W/VITAMIN B6) (View Magne B6 (magnesium W/vitamin B6) Review and Magne B6 (magnesium W/vitamin B6) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LEXOMIL (BROMAZEPAM) (View Lexomil (bromazepam) Review and Lexomil (bromazepam) Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

6759966-7 | Cardiac Disorder
Adverse event was reported on May 20, 2010 by a Male patient taking Saizen (View Usage) (Dosage: 8 Mg) . Location: ARGENTINA , 17 years of age, After Saizen was administered, patient had the following side effects: cardiac disorder.

6759800-5 | Brain Abscess
on May 20, 2010 Female patient from FRANCE , 21 years of age, was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: brain abscess. Saizen dosage: . Patient was hospitalized and became disabled.

6747039-9 | Hypercholesterolaemia, Low Density Lipoprotein Increased
on May 13, 2010 Male patient from SPAIN , child 6 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient had the following side effects: hypercholesterolaemia, low density lipoprotein increased. Saizen dosage: 0.55 Mg, Subcutaneous.

6740696-2 | Off Label Use
Patient was taking Saizen (View Usage). After Saizen was administered, patient had the following side effects: off label use on May 10, 2010 from BRAZIL Additional patient health information: Male patient , 64 years of age, was diagnosed with elderly and. Saizen dosage: 8 Mg, 1 In 1 D, Subcutaneous.

6738350-6 | Asthenia, Fatigue, Malaise, Pain, Pituitary Tumour
Adverse event was reported on May 07, 2010 by a Female patient taking Saizen (View Usage) (Dosage: 8.8 Mg, 1 In 1 D) was diagnosed with blood growth hormone and. Location: CANADA , 45 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, fatigue, malaise, pain (What is pain?), pituitary tumour.

6733073-1 | Cardiac Disorder
on May 03, 2010 Male patient from ARGENTINA , 17 years of age, was treated with Saizen (View Usage). Patient had the following side effects: cardiac disorder. Saizen dosage: 8 Mg.

6733071-8 | Asthenia, Confusional State, Cough, Disorientation, Dry Mouth, Malaise
on Apr 30, 2010 Male patient from IRELAND , 70 years of age, weighting 238.1 lb, was diagnosed with pituitary cancer metastatic and was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: asthenia, confusional state, cough, disorientation, dry mouth, malaise. Saizen dosage: 0.2 Mg, Subcutaneous. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), XALATAN (View Xalatan Review and Xalatan Label ), NEBIDO (View Nebido Review and Nebido Label ), CALCICHEW D3 FORTE (LEKOBIT CA) (View Calcichew D3 Forte (lekobit Ca) Review and Calcichew D3 Forte (lekobit Ca) Label ), TEVETEN HCT (View Teveten Hct Review and Teveten Hct Label ), CAPRIN (ACETYLSALICYLIC ACID) (View Caprin (acetylsalicylic Acid) Review and Caprin (acetylsalicylic Acid) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6727982-7 | Benign Intracranial Hypertension, Headache, Strabismus, Viral Infection
Patient was taking Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: benign intracranial hypertension, headache (What is headache?), strabismus, viral infection (What is viral infection?) on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, was diagnosed with cystic fibrosis and. Saizen dosage: 1.7 Mg. Patient was hospitalized.

6718647-6 | Convulsion, Nervous System Disorder, No Therapeutic Response
Adverse event was reported on Apr 22, 2010 by a Female patient taking Saizen (View Usage) (Dosage: 8 Mg, 1 In 1 D, Subcutaneous) . Location: BRAZIL , child 2 years of age, Patient had the following side effects: convulsion, nervous system disorder, no therapeutic response. Patient was hospitalized.

6717130-1 | Benign Intracranial Hypertension, No Therapeutic Response, Strabismus, Viral Infection
on Apr 22, 2010 Male patient from UNITED STATES , child 12 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). After Saizen was administered, patient had the following side effects: benign intracranial hypertension, no therapeutic response, strabismus, viral infection (What is viral infection?). Saizen dosage: 1.7 Mg. Patient was hospitalized.

6716897-6 | Bacterial Sepsis, Device Related Infection, Diarrhoea, Immune System Disorder, Injection Site Pain, Malabsorption, Scratch, Septic Shock
on Apr 15, 2010 Male patient from UNITED STATES , child 11 years of age, was diagnosed with growth hormone deficiency and was treated with Saizen (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial sepsis, device related infection, diarrhoea, immune system disorder, injection site pain, malabsorption, scratch, septic shock. Saizen dosage: 0.9 Mg. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6716890-3 | Asthenia, Blood Glucose Decreased, Convulsion, Dyspnoea
Patient was taking Saizen (View Usage). Patient had the following side effects: asthenia, blood glucose decreased, convulsion, dyspnoea on Apr 15, 2010 from UNITED STATES Additional patient health information: Female patient , child 2 years of age, . Saizen dosage: 0.4 Mg.